Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Akinori, Sasaki"'
Autor:
Akinori Sasaki, Yutaro Fujimoto, Takashi Inada, Azusa Ishizuka, Jun Ehara, Shin Ogita, Yasuhiro Norisue
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-9 (2023)
Abstract Background Current guidelines for non-small-cell lung cancer (NSCLC) recommend that each tyrosine kinase inhibitor (TKI) is indicated even for driver mutation-positive patients with a poor performance status (PS). In previous studies, most p
Externí odkaz:
https://doaj.org/article/9def0f081e0346e0a967a8e60a848ddf
Publikováno v:
Journal of Digestive Endoscopy, Vol 13, Iss 04, Pp 229-234 (2022)
Objectives Endoscopic mucosal resection (EMR) is useful for removing colon polyps and is generally carried out by one doctor. It is occasionally difficult for colorectal polyps to be removed by EMR. In such cases, EMR is performed by the main doctor
Externí odkaz:
https://doaj.org/article/1a59af1036604f8ea1bf63031eb5b8b1
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Patients with advanced duodenal carcinoma usually have a poor prognosis due to limited effective chemotherapy options. The study for genotype-directed therapy in patients with duodenal carcinoma is progressing. However, no clinical data assessing the
Externí odkaz:
https://doaj.org/article/dccde098e5d447e0ab45e3b21e314f5c
Autor:
Hiroshi Yamazaki, Akinori Sasaki, Eriko Yamaguchi, Kana Sawada, Risa Okamoto, Kuniyasu Saigusa, Yasuaki Motomura
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2022 (2022)
Cerebral venous thrombosis (CVT) is a rare complication of ulcerative colitis (UC) that is potentially fatal once it occurs. This report describes a case of CVT that led to a diagnosis of UC. A 48-year-old woman was diagnosed with CVT due to paresthe
Externí odkaz:
https://doaj.org/article/a2ff61e644024960bdec75396ba3aece
Publikováno v:
Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo). 126:698-703
Autor:
Akinori Sasaki, Naonori Hu, Nishiki Matsubayashi, Takushi Takata, Yoshinori Sakurai, Minoru Suzuki, Hiroki Tanaka
Publikováno v:
Journal of Radiation Research. 64(3):602-611
To treat superficial tumors using accelerator-based boron neutron capture therapy (ABBNCT), a technique was investigated, based on which, a single-neutron modulator was placed inside a collimator and was irradiated with thermal neutrons. In large tum
Publikováno v:
American Journal of Case Reports. 9/13/2022, Vol. 23, p1-6. 6p.
Autor:
Saori Mishima, Akihito Kawazoe, Yoshiaki Nakamura, Akinori Sasaki, Daisuke Kotani, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Toshihiko Doi, Atsushi Ohtsu, Takayuki Yoshino, Takeshi Kuwata, Akihito Tsuji, Kohei Shitara
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Abstract Background Clinicopathological and molecular features of responders to nivolumab for advanced gastric cancer (AGC) are not well understood. Methods Patients (pts) with AGC who were treated with nivolumab after two or more chemotherapy regime
Externí odkaz:
https://doaj.org/article/6bb077a4afc0401982a619dd6d4c130c
Autor:
Saori Mishima, Akihito Kawazoe, Yasutoshi Kuboki, Takashi Kojima, Toshihiko Doi, Takayuki Yoshino, Kohei Shitara, Yoshiaki Nakamura, Kentaro Sawada, Hiroya Taniguchi, Daisuke Kotani, Akinori Sasaki, Testuya Eto, Mashiro Okunaka, Tetsuo Akimoto
Publikováno v:
ESMO Open, Vol 5, Iss 4 (2020)
Background The efficacy and safety of chemotherapy (CTx) after anti-PD-1 therapy in patients with advanced gastric cancer (AGC) remains unclear.Methods Medical records of consecutive patients with AGC treated with both CTx (taxanes plus ramucirumab,
Externí odkaz:
https://doaj.org/article/c56062b65bfe468ca4cdc42f9348246c
Autor:
Takahiro Ishii, Akihito Kawazoe, Akinori Sasaki, Saori Mishima, Sawada Kentaro, Yoshiaki Nakamura, Daisuke Kotani, Yasutoshi Kuboki, Hiroya Taniguchi, Takashi Kojima, Toshihiko Doi, Takayuki Yoshino, Takeshi Kuwata, Genichiro Ishii, Kohei Shitara
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: The use of nivolumab or irinotecan as the third-line treatment for patients with advanced gastric cancer (AGC) remains controversial. Methods: This study analyzed patients with AGC treated with nivolumab or irinotecan (nivolumab group or
Externí odkaz:
https://doaj.org/article/f251f1ba806640e095518e9cbb5e26dc